Patents
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
10/2003
10/15/2003CN1448502A Green muscardine and use thereof
10/15/2003CN1448501A Process for producing a culture of antrodia camphorata and product obtained thereby
10/15/2003CN1124350C Strain of the microorganism penicillium oxalicum Var armeniaca and its application
10/15/2003CN1124348C Multi-functional hematopoietic receptor agonists
10/15/2003CN1124344C Production of D-pantoic acid and D-pantothenic acid
10/15/2003CN1124340C Process for producing L-valine and L-leucine
10/14/2003US6632935 Genome DNA of bacterial symbiont of aphids
10/14/2003US6632926 Amino acids inserted in hypervariable region; heavy chain variable domain of an antibody that binds vascular endothelial growth factor
10/14/2003US6632923 Low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis
10/14/2003US6632920 Immunology; diagnosing cancer, nervous system, brain, sleep, psychological, and disorders
10/14/2003US6632673 Mutation results in substitution in gene; genetic engineering
10/14/2003US6632662 Container comprising small and large-sized magnetic particles which move in grinding motion in response to a magnetic field
10/14/2003US6632661 Apparatus for the propagation of microorganisms
10/14/2003US6632650 Genes involved in cyclododecanone degradation pathway
10/14/2003US6632649 Culturing; cobalt salt, air, oxygen; useful for water treatment; tert-amyl methyl ether; methyl tert-butyl ether; ethyl tert-butyl ether
10/14/2003US6632646 Modified subtilisins and detergent compositions containing same
10/14/2003US6632645 Of given amino acid sequence; use in sequencing, reverse transcription, and amplification reactions
10/14/2003US6632644 Nucleotide sequences which code for the zwa1 gene
10/14/2003US6632639 Gene encoding RNase E comprises a mutation such that the enzyme produced upon expression does not degrade messsenger RNA; substitution of guanine by thymidine to create a stop codon
10/14/2003US6632635 Methods of refolding proteins
10/14/2003US6632625 Ob (obesity gene); receptors may be used in various assays, such as a transactivation assay to identify novel ligands
10/14/2003US6632601 Immunoassays for anti-HCV antibodies
10/14/2003US6632441 Mutants of streptococcal toxin a and methods of use
10/14/2003US6632428 Hyperlipidemia, lowering both the serum cholesterol and serum triglyceride levels, culturing a Lovastatin-producing Monascus strain
10/14/2003US6632365 Digestion and oxidation of sludge
10/14/2003CA2114104C Nucleotide sequences of galactinol synthase from zucchini and soybean
10/14/2003CA2080018C Novel t-cell lymphoma cdna clones
10/14/2003CA2066561C Methods for rapid microbial detection
10/12/2003CA2425021A1 Control of the ratio of lap to lip
10/09/2003WO2003083136A1 Method and kit for detecting membrane protein-protein interactions
10/09/2003WO2003083125A1 Ehanced protein expression in bacillus
10/09/2003WO2003083123A2 Improved method for the production of vitamin b12
10/09/2003WO2003083114A1 Antiopoietin-related growth factor
10/09/2003WO2003083113A2 Growth regulating proteins
10/09/2003WO2003083110A1 Novel galactose transferases, peptides thereof and nucleic acid encoding the same
10/09/2003WO2003083109A1 Selection marker gene
10/09/2003WO2003083098A2 Nucleic acid sequence and protein in addition to polypeptides coding for mannitol-dehydrogenases or parts thereof and the production and use thereof in diagnosis and therapy
10/09/2003WO2003083087A1 Method and cloning vectors utilizing intergeneric conjugation for manipulation of actinomycetes biosynthesis genes
10/09/2003WO2003083056A2 Secretion of proteins with multiple disulfide bonds in bacteria and uses thereof
10/09/2003WO2003083054A2 Amylases, nucleic acids encoding them and methods for making and using them
10/09/2003WO2003083043A2 Methods for producing secreted polypeptides having l-asparaginase activity
10/09/2003WO2003083039A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/09/2003WO2003082923A1 Process for crosslinking polypeptides
10/09/2003WO2003082917A1 Novel polypeptide and nucleic acid encoding the same
10/09/2003WO2003082909A1 Non-ribosomal peptide synthetases and associated biosynthetic genes
10/09/2003WO2003082196A2 Combination therapy using trefoil peptides
10/09/2003WO2003082184A2 Truncated lysostaphin molecule with enhanced staphylolytic activity
10/09/2003WO2003082027A1 Vital cell preparations containing lactic acid bacterium as the active ingredient and lactic acid bacterium-containing foods
10/09/2003WO2003082019A2 Peptides with anti-hypertensive properties
10/09/2003WO2003051111A3 Cryopreservation of biological materials using pre-chilled protectant
10/09/2003WO2003040170A3 Antibodies to cd40
10/09/2003WO2003037367A3 New bacterium causing poultry disease and vaccine derived thereof
10/09/2003WO2003022880A3 Synthetic hcv envelope proteins and their use for vaccination
10/09/2003WO2003020928A3 Identification of eukaryotic internal ribosome entry site (ires) elements
10/09/2003WO2003008437A3 Protein and nucleic acid expression systems
10/09/2003WO2003007889A3 Therapeutic agents comprising pro-apoptotic proteins
10/09/2003WO2003000884A3 Cytochrome p-450 gene cluster from rhodococcus ruber and uses thereof in ether fuel cleavage
10/09/2003WO2003000878A3 Use of fkbp chaperones as expression tool
10/09/2003WO2002097075A3 Capping enzyme of flavivirus and utilization of this protein in a process to test drugs with antiviral properties
10/09/2003WO2002083929A3 System and method for quantitating transcription factors
10/09/2003WO2002070701A3 Novel human gnrh receptor
10/09/2003WO2002066629A3 Recombinant vector containing infectious human cytomegalovirus genome with preserved wild-type characteristics of clinical isolates
10/09/2003WO2002059154A3 Neutralizing human monoclonal antibodies against hiv-1, their production and uses
10/09/2003WO2002040676A3 Mutant allergens
10/09/2003WO2002033099A3 Human kinases
10/09/2003WO2002031160A3 Regulation of human phospholipase a2-like enzyme
10/09/2003WO2002020563A3 RECEPTOR IN THE EDb FIBRONECTIN DOMAIN
10/09/2003WO2002016612A3 Genes and proteins, and their uses
10/09/2003WO2002012290A3 Sid polypeptides binding to pathogenic strain of the hepatitis c virus
10/09/2003WO2002010382A3 Trp8, trp9 and trp10, markers for cancer
10/09/2003WO2002006313A3 Regulation of human glutamate receptor delta-1 subunit
10/09/2003US20030192075 Elicitor from cladosporium
10/09/2003US20030191301 Nucleic acid molecule encoding a gene product which, when knocked out, or prevented from expression results in a high growth phenotype
10/09/2003US20030191290 Antibody that binds to the protein; given amino acid sequence
10/09/2003US20030191289 Antibody that binds to the protein; given amino acid sequence
10/09/2003US20030191288 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/09/2003US20030191287 Antibody that binds to the protein; given amino acid sequence
10/09/2003US20030191285 Novel g protein-coupled receptor proteins and dnas thereof
10/09/2003US20030191284 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/09/2003US20030191277 Comprising a connecting peptide with aromatic amino acid residue and a cleavage site; transforming a yeast cell with expression vector; increased folding stability
10/09/2003US20030191080 Cardiovascular disorders; hypotensive agents
10/09/2003US20030191062 Bone marrow specific protein
10/09/2003US20030191039 Modified subtilisins and detergent, compositions containing same
10/09/2003US20030191038 Subtilase enzymes
10/09/2003US20030190752 Escherichia coli csrB gene, RNA encoded thereby, and methods of use thereof
10/09/2003US20030190751 Directed switch-mediated DNA recombination
10/09/2003US20030190749 Expression element that comprises a gene linked to sequences that are inducible and/or repressible; mutations; useful in diagnositics, therapeutics and drug discovery
10/09/2003US20030190747 Method of preparing culture support factor from insects
10/09/2003US20030190741 Useful as an additive for feeds and in the decomposition of hemicellulose
10/09/2003US20030190739 Tankyrase2 materials and methods
10/09/2003US20030190737 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in genetically modified cells
10/09/2003US20030190734 Invention provides DNAs, vectors and host cells for the efficient production of various enzymes in the mevalonate pathway or for converting isopentyl pyrophosphate to farnesyl pyrophosphate synthase
10/09/2003US20030190733 Desaturase genes and uses thereof
10/09/2003US20030190716 Used to produce pharmaceuticals, diagnostics, biosensors, bioreactors; PRO polypeptides
10/09/2003US20030190715 Novel proteins and nucleic acids encoding same
10/09/2003US20030190712 Fermentation process for the preparation of L-threonine
10/09/2003US20030190711 Novel insulin synthase and process for producing inulin by using the same
10/09/2003US20030190708 Novel hepatoma-derived growth factor-like proteins, polynucleotides encoding them and methods of use
10/09/2003US20030190707 17 human secreted proteins
10/09/2003US20030190706 Novel promoters and gene expression method by using the promoters